GLP-1s Are Shrinking More Than Your Waistline

Authors

Editorial Team, The Peptide Dispatch

Journal

The Peptide Dispatch

Published

March 16, 2026

Overview

This dispatch covers GLP-1s Are Shrinking More Than Your Waistline in the Metabolic research category, authored by Editorial Team, The Peptide Dispatch, originally published in The Peptide Dispatch on March 16, 2026. Estimated reading time: 8 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.

Abstract

New research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may reduce addiction signals, lower inflammation markers, and even slow cardiac remodeling — effects that extend well beyond appetite suppression. We review the emerging evidence and what it means for the peptide research community.

Topics Covered

More from the Research Library

• Your Thyroid Panel Is One Number — And That's Why You Still Feel Like Garbage — research
• Hot Take: The FDA Just Quietly Moved 12 Peptides — And It is Not What Most Clinics Are Telling You — research
• Your Cells Are Running Out of Fuel — And No Standard Blood Panel Is Checking — research
• The 2026 Cholesterol Guidelines Just Changed Everything — And Your Doctor Still Isn't Testing ApoB — research
• You're Hemorrhaging Growth Hormone Every Night — And Your Sleep Tracker Can't See It — research
• Your Cortisol Is Wrecking Your Metabolism — And Your Doctor Isn't Testing It — research

All information is presented for Research Use Only (RUO). Not medical advice.